Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    October 2017
  1. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Age, Vascular Health, and Alzheimer's disease Biomarkers in an Elderly Sample.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25071.
    PubMed     Text format     Abstract available


    September 2017
  2. BOROS BD, Greathouse KM, Gentry EG, Curtis KA, et al
    Dendritic spines provide cognitive resilience against Alzheimer's disease.
    Ann Neurol. 2017 Sep 16. doi: 10.1002/ana.25049.
    PubMed     Text format     Abstract available


  3. TAN CH, Hyman BT, Tan JJX, Hess CP, et al
    Polygenic hazard scores in preclinical Alzheimer disease.
    Ann Neurol. 2017;82:484-488.
    PubMed     Text format     Abstract available


    August 2017
  4. IRWIN DJ, Lleo A, Xie SX, McMillan CT, et al
    Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Ann Neurol. 2017;82:247-258.
    PubMed     Text format     Abstract available


    July 2017
  5. ESCOTT-PRICE V, Myers AJ, Huentelman M, Hardy J, et al
    Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer's Disease.
    Ann Neurol. 2017 Jul 20. doi: 10.1002/ana.24999.
    PubMed     Text format     Abstract available


    June 2017
  6. VASSILAKI M, Christianson TJ, Mielke MM, Geda YE, et al
    Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.
    Ann Neurol. 2017;81:871-882.
    PubMed     Text format     Abstract available


    May 2017
  7. MARTISKAINEN H, Herukka SK, Stancakova A, Paananen J, et al
    Decreased plasma beta-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24969.
    PubMed     Text format     Abstract available


  8. TIJMS BM, Bertens D, Slot RE, Gouw AA, et al
    Low normal cerebrospinal fluid Abeta42 levels predict clinical progression in nondemented subjects.
    Ann Neurol. 2017;81:749-753.
    PubMed     Text format     Abstract available


    April 2017
  9. MENG Y, Volpini M, Black S, Lozano AM, et al
    Focused ultrasound as a novel strategy for Alzheimer's disease therapeutics.
    Ann Neurol. 2017 Apr 10. doi: 10.1002/ana.24933.
    PubMed     Text format     Abstract available


  10. HANSEEUW BJ, Betensky RA, Schultz AP, Papp KV, et al
    Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
    Ann Neurol. 2017;81:583-596.
    PubMed     Text format     Abstract available


  11. ABNER EL, Kryscio RJ, Schmitt FA, Fardo DW, et al
    Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.
    Ann Neurol. 2017;81:549-559.
    PubMed     Text format     Abstract available


    March 2017
  12. SPINELLI EG, Mandelli ML, Miller ZA, Santos-Santos MA, et al
    Typical and atypical pathology in primary progressive aphasia variants.
    Ann Neurol. 2017;81:430-443.
    PubMed     Text format     Abstract available


    December 2016
  13. MARQUIE M, Normandin MD, Meltzer AC, Siao Tick Chong M, et al
    Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies.
    Ann Neurol. 2016 Dec 20. doi: 10.1002/ana.24844.
    PubMed     Text format     Abstract available


    November 2016
  14. KANTARCI K, Lowe VJ, Boeve BF, Senjem ML, et al
    AV-1451 Tau and beta-Amyloid PET Imaging in Dementia with Lewy Bodies.
    Ann Neurol. 2016 Nov 18. doi: 10.1002/ana.24825.
    PubMed     Text format     Abstract available


    October 2016
  15. ALBERS AD, Asafu-Adjei J, Delaney MK, Kelly KE, et al
    Episodic Memory of Odors Stratifies Alzheimer Biomarkers in Normal Elderly.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24792.
    PubMed     Text format     Abstract available


  16. VOSSEL KA, Ranasinghe KG, Beagle AJ, Mizuiri D, et al
    Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24794.
    PubMed     Text format     Abstract available


    August 2016
  17. BAYKARA E, Gesierich B, Adam R, Tuladhar AM, et al
    A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.
    Ann Neurol. 2016 Aug 12. doi: 10.1002/ana.24758.
    PubMed     Text format     Abstract available


    July 2016
  18. VLASSENKO AG, McCue L, Jasielec MS, Su Y, et al
    Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24719.
    PubMed     Text format     Abstract available


  19. TIRABOSCHI P, Corso A, Guerra UP, Nobili F, et al
    123 I-FP-CIT SPECT and 123 I-MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24717.
    PubMed     Text format     Abstract available


    June 2016
  20. TAKEDA S, Commins C, DeVos SL, Nobuhara CK, et al
    Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
    Ann Neurol. 2016 Jun 28. doi: 10.1002/ana.24716.
    PubMed     Text format     Abstract available


  21. CHO H, Choi JY, Hwang MS, Kim YJ, et al
    In vivo cortical spreading pattern of tau and amyloid in the Alzheimer's disease spectrum.
    Ann Neurol. 2016 Jun 20. doi: 10.1002/ana.24711.
    PubMed     Text format     Abstract available


  22. HOEKSTRA JG, Hipp MJ, Montine TJ, Kennedy SR, et al
    Mitochondrial DNA Mutations Increase in Early Stage Alzheimer's Disease and are Inconsistent with Oxidative Damage.
    Ann Neurol. 2016 Jun 17. doi: 10.1002/ana.24709.
    PubMed     Text format     Abstract available


  23. DI LORENZO F, Ponzo V, Bonni S, Motta C, et al
    LTP-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset.
    Ann Neurol. 2016 Jun 3. doi: 10.1002/ana.24695.
    PubMed     Text format     Abstract available


    March 2016
  24. LEE S, Viqar F, Zimmerman ME, Narkhede A, et al
    White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network.
    Ann Neurol. 2016 Mar 26. doi: 10.1002/ana.24647.
    PubMed     Text format     Abstract available


    February 2016
  25. TRAYLOR M, Adib-Samii P, Harold D, Dichgans M, et al
    Shared genetic contribution to Ischaemic Stroke and Alzheimer's Disease.
    Ann Neurol. 2016 Feb 23. doi: 10.1002/ana.24621.
    PubMed     Text format     Abstract available


    October 2015
  26. LA MORGIA C, Ross-Cisneros FN, Koronyo Y, Hannibal J, et al
    Melanopsin retinal ganglion cell loss in Alzheimer's disease.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24548.
    PubMed     Text format     Abstract available


  27. JOHNSON KA, Schultz A, Betensky RA, Becker JA, et al
    Tau PET imaging in aging and early Alzheimer's disease.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24546.
    PubMed     Text format     Abstract available


  28. REPLOGLE JM, De Jager PL
    Reply: To PMID 25545807.
    Ann Neurol. 2015;78:659-60.
    PubMed     Text format    


    September 2015
  29. MARQUIE M, Normandin MD, Vanderburg CR, Costantino I, et al
    Validating novel tau PET tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Ann Neurol. 2015 Sep 7. doi: 10.1002/ana.24517.
    PubMed     Text format     Abstract available


    August 2015
  30. LIU G, Jiang Q, Xu A, Li K, et al
    REST rs3796529 variant does not confer susceptibility to Alzheimer's disease.
    Ann Neurol. 2015 Aug 18. doi: 10.1002/ana.24503.
    PubMed     Text format    


  31. WANG JL, Lim AS, Chiang WY, Hsieh WH, et al
    Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans.
    Ann Neurol. 2015;78:317-22.
    PubMed     Text format     Abstract available


    July 2015
  32. JOSEPHS KA, Whitwell JL, Tosakulwong N, Weigand SD, et al
    TDP-43 and pathological subtype of Alzheimer's disease impact clinical features.
    Ann Neurol. 2015 Jul 29. doi: 10.1002/ana.24493.
    PubMed     Text format     Abstract available


  33. DOLS-ICARDO O, Vilaplana E, Sampedro F, Alcolea D, et al
    Effect of REST on brain metabolism in the Alzheimer's disease continuum.
    Ann Neurol. 2015 Jul 15. doi: 10.1002/ana.24484.
    PubMed     Text format    


  34. ALBIN RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, et al
    Post-Mortem Evaluation of Amyloid-Dopamine Terminal PET Dementia Classifications.
    Ann Neurol. 2015 Jul 15. doi: 10.1002/ana.24481.
    PubMed     Text format     Abstract available


  35. VANDERHORST VG, Samardzic T, Saper CB, Anderson MP, et al
    alpha-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
    Ann Neurol. 2015;78:142-9.
    PubMed     Text format     Abstract available


    June 2015
  36. VARDARAJAN BN, Ghani M, Kahn A, Sheikh S, et al
    Rare coding mutations identified by sequencing of Alzheimer's disease GWAS loci.
    Ann Neurol. 2015 Jun 23. doi: 10.1002/ana.24466.
    PubMed     Text format     Abstract available


  37. PERROTIN A, Desgranges B, Landeau B, Mezenge F, et al
    Anosognosia in Alzheimer disease: Disconnection between memory and self networks.
    Ann Neurol. 2015 Jun 18. doi: 10.1002/ana.24462.
    PubMed     Text format     Abstract available


  38. LIU G
    No association of TREM1 rs6910730 and TREM2 rs7759295 with Alzheimer's disease.
    Ann Neurol. 2015 Jun 9. doi: 10.1002/ana.24458.
    PubMed     Text format    


    April 2015
  39. ZHOU Q, Wang M, Du Y, Zhang W, et al
    Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
    Ann Neurol. 2015;77:637-54.
    PubMed     Text format     Abstract available


    February 2015
  40. MICHAILIDOU I, Willems JG, Kooi EJ, van Eden C, et al
    Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
    Ann Neurol. 2015 Feb 27. doi: 10.1002/ana.24398.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: